Doctor profile · Federal record
Dr. MARTHA PASSEK, CNP
Adult Health Nurse Practitioner (CMS: NURSE PRACTITIONER) · RAVENNA, OH
- NPI 1689693277
- Accepts Medicare
- MIPS 90.9 / 100 · 2023
- 24 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
6847 N CHESTNUT ST, SUITE 100
RAVENNA, OH 442663929
(330) 297-6110
fax (330) 296-0592
Credentials & registration
- NPI registered
- July 2006 — 20 yrs on file
- Profile last updated
- November 27, 2020
- Year of graduation
- 2002 — 24 yrs since
- Specialty taxonomy
- 363LA2200X — NUCC code
- State license (1)
- Ohio #NP07179
- Medicaid
- OH #2432871
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1689693277. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
386
Distinct HCPCS
4
Medicare allowed
$26,970
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99232 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 165 | 94 | $65 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 97 | 89 | $105 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 75 | 71 | $73 | |
93000 |
Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 49 | 46 | $12 |
In context: peer comparison
Among 3 peers in this city , average services per provider: 61. This provider delivers 6.3× the peer median.Open Payments
Industry payments received
All-time total
$706
Transactions
37
Manufacturers
14
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | 8 | $168.69 | |
| PFIZER INC. | 5 | $95.98 | |
| HEARTFLOW, INC. | 1 | $76.48 | |
| AstraZeneca Pharmaceuticals LP | 3 | $65.64 | |
| Amgen Inc. | 3 | $46.03 | |
| Kiniksa Pharmaceuticals International, plc | 3 | $44.68 | |
| Novo Nordisk Inc | 2 | $41.34 | |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 4 | $38.13 | |
| Janssen Pharmaceuticals, Inc | 2 | $33.45 | |
| E.R. Squibb & Sons, L.L.C. | 2 | $29.79 | |
| Abbott Laboratories | 1 | $17.87 | |
| United Therapeutics Corporation | 1 | $17.54 | |
| Actelion Pharmaceuticals US, Inc. | 1 | $15.26 | |
| Bard Peripheral Vascular, Inc. | 1 | $15.01 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
759
Patients
396
Total drug cost
$161,296
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Eliquis (Apixaban) | Brand | 89 | 46 | $113,109 |
| Amlodipine Besylate | Generic | 86 | 41 | $562 |
| Atorvastatin Calcium | Generic | 83 | 44 | $1,467 |
| Lisinopril | Generic | 83 | 44 | $750 |
| Metoprolol Succinate | Generic | 67 | 40 | $1,778 |
| Metoprolol Tartrate | Generic | 60 | 35 | $648 |
| Carvedilol | Generic | 49 | 28 | $619 |
| Furosemide | Generic | 49 | 28 | $229 |
| Hydrochlorothiazide | Generic | 44 | 17 | $172 |
| Rosuvastatin Calcium | Generic | 40 | 17 | $318 |